세계의 맞춤형 유전자 치료 시장 보고서(2025년)

Personalized gene therapy treatment refers to specialized medical care that delivers targeted therapies tailored to an individual's unique genetic profile. It involves modifying, repairing, or replacing faulty genes to directly address the root causes of genetic disorders. Personalized gene therapy treatment improves precision of care, reduces the risk of adverse effects, and enhances overall therapeutic outcomes.

The primary types of personalized gene therapy treatments include targeted treatments and pharmacogenomics. Targeted treatments are therapies specifically designed to modify or regulate particular genes linked to a disease in order to maximize therapeutic benefit while minimizing side effects. The vector types include viral and nonviral approaches and are administered through various distribution channels such as hospitals, clinics, home administration, and others. These treatments are applied across diverse medical areas, including oncology, neurology, hematology, infectious diseases, ophthalmology, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The personalized gene therapy treatments market research report is one of a series of new reports from The Business Research Company that provides personalized gene therapy treatments market statistics, including personalized gene therapy treatments industry global market size, regional shares, competitors with a personalized gene therapy treatments market share, detailed personalized gene therapy treatments market segments, market trends and opportunities, and any further data you may need to thrive in the personalized gene therapy treatments industry. The personalized gene therapy treatments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The personalized gene therapy treatment market size has grown exponentially in recent years. It will grow from $6.93 billion in 2024 to $8.38 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth during the historic period is driven by the increasing prevalence of genetic disorders, progress in gene editing technologies, rising awareness of personalized medicine, supportive government initiatives and funding, and expansion of biotechnology research and infrastructure.

The personalized gene therapy treatment market size is expected to see exponential growth in the next few years. It will grow to $17.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth during the forecast period is fueled by the expansion of clinical trials for gene therapies, the integration of artificial intelligence and predictive analytics in treatment design, increasing collaborations between pharmaceutical and biotechnology companies, the development of safer and more efficient delivery vectors, and the rising demand for targeted and precision therapies. The primary trends in the forecast period include integration of artificial intelligence and machine learning in therapy design, expansion of genomic sequencing capabilities, growth in collaborations between biotechnology and pharmaceutical companies, automation in gene therapy manufacturing processes, and adoption of blockchain technology for genetic data security.

The increasing prevalence of genetic disorders is expected to drive the growth of the personalized gene therapy treatment market. Genetic disorders arise from DNA abnormalities that disrupt normal bodily functions, and their prevalence is rising due to factors such as increasing parental age, where older reproductive cells carry a higher risk of passing mutations to offspring. Personalized gene therapy offers a solution by directly correcting the faulty genes responsible for the condition and customizing treatment based on an individual's genetic profile. This approach enhances the efficacy of treatment and reduces side effects. For example, in September 2023, the Cystic Fibrosis Trust reported that the number of cystic fibrosis (CF) patients in the UK increased to 11,148 in 2022, up from 10,908 in 2021. As a result, the growing prevalence of genetic disorders is contributing to the expansion of the personalized gene therapy treatment market.

Key players in the personalized gene therapy treatment market are focusing on strategic partnerships to enhance their technological capabilities and accelerate the delivery of innovative therapies. These partnerships allow companies to combine resources and expertise, sharing both the risks and rewards of new developments. For example, in May 2025, Aldevron, a US-based company specializing in the production of DNA, RNA, and proteins, partnered with Integrated DNA Technologies, a US-based provider of genomics solutions, to create the world's first mRNA-based personalized CRISPR therapy for a rare and life-threatening genetic condition called urea cycle disorder (UCD). This "N of 1" therapy was developed in just six months, incorporating a custom guide RNA, mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The success of this therapy represents a significant milestone in personalized in vivo base-editing treatments.

In July 2025, Eli Lilly and Company, a US-based pharmaceutical company, acquired Verve Therapeutics Inc. for $1.3 billion. This acquisition allows Eli Lilly to expand its gene-editing portfolio into cardiovascular diseases and strengthens its position in the personalized gene therapy market. Verve Therapeutics, a clinical-stage company, is focused on developing one-time base-editing gene therapies specifically for cardiovascular conditions.

Major players in the personalized gene therapy treatment market are Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Kyowa Kirin Co. Ltd., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Rocket Pharmaceuticals Inc., REGENXBIO Inc., Intellia Therapeutics Inc., Beam Therapeutics Inc., Adaptimmune Therapeutics plc, Krystal Biotech Inc., Miltenyi Biomedicine GmbH, Bluebird Bio Inc., uniQure N.V., Mesoblast Limited, Astellas Gene Therapies Inc., Adverum Biotechnologies Inc., Autolus Therapeutics plc.

North America was the largest region in the personalized gene therapy treatment market in 2024. The regions covered in personalized gene therapy treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized gene therapy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized gene therapy treatment market consists of revenues earned by entities by providing services such as genetic testing and diagnostics, personalized therapy design, gene editing treatments, viral and non-viral vector delivery, patient-specific cell therapies, and post-treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized gene therapy treatment market also includes sales of viral vectors, gene editing platforms, cell culture systems, bioprocessing tools, and monitoring software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Gene Therapy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized gene therapy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized gene therapy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized gene therapy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy: Targeted Treatments; Pharmacogenomics
• 2) By Vector Type: Viral; Non-Viral
• 3) By Distribution Channel: Hospitals; Clinics; Home Administration; Other Distribution Channels
• 4) By Application: Oncology; Neurology; Hematological; Infectious Diseases; Ophthalmology; Other Applications
• Subsegments:
• 1) By Targeted Treatments: Monoclonal Antibodies; Chimeric Antigen Receptor T-Cell Therapy (CAR-T); Small Interfering RNA (siRNA) Therapy; Antisense Oligonucleotides (ASO); Gene Editing Therapy
• 2) By Pharmacogenomics: Companion Diagnostics; Drug Metabolism Enzyme Testing; Genetic Biomarker Analysis; Single Nucleotide Polymorphism (SNP) Profiling; Adverse Drug Reaction (ADR) Prediction
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Invitae Corporation; Guardant Health Inc.; GeneDx LLC; Ancestry Inc.; Oxford Nanopore Technologies plc; Genomic Health Inc.; 23andMe Holding Co.; Color Health Inc.; Helix OpCo LLC; Personalis Inc.; Dante Genomics; Gene By Gene Ltd.; Veritas Genetics Inc.; Futura Genetics; Nebula Genomics Inc.; Pathway Genomics Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Gene Therapy Treatment Market Characteristics

3. Personalized Gene Therapy Treatment Market Trends And Strategies

4. Personalized Gene Therapy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Gene Therapy Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Gene Therapy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Gene Therapy Treatment Market Growth Rate Analysis
• 5.4. Global Personalized Gene Therapy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Gene Therapy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Gene Therapy Treatment Total Addressable Market (TAM)

6. Personalized Gene Therapy Treatment Market Segmentation

• 6.1. Global Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Treatments
• Pharmacogenomics
• 6.2. Global Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral
• Non-Viral
• 6.3. Global Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Administration
• Other Distribution Channels
• 6.4. Global Personalized Gene Therapy Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Hematological
• Infectious Diseases
• Ophthalmology
• Other Applications
• 6.5. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Targeted Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Chimeric Antigen Receptor T-Cell Therapy (CAR-T)
• Small Interfering RNA (siRNA) Therapy
• Antisense Oligonucleotides (ASO)
• Gene Editing Therapy
• 6.6. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Diagnostics
• Drug Metabolism Enzyme Testing
• Genetic Biomarker Analysis
• Single Nucleotide Polymorphism (SNP) Profiling
• Adverse Drug Reaction (ADR) Prediction

7. Personalized Gene Therapy Treatment Market Regional And Country Analysis

• 7.1. Global Personalized Gene Therapy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Gene Therapy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Gene Therapy Treatment Market

• 8.1. Asia-Pacific Personalized Gene Therapy Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Gene Therapy Treatment Market

• 9.1. China Personalized Gene Therapy Treatment Market Overview
• 9.2. China Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Gene Therapy Treatment Market

• 10.1. India Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Gene Therapy Treatment Market

• 11.1. Japan Personalized Gene Therapy Treatment Market Overview
• 11.2. Japan Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Gene Therapy Treatment Market

• 12.1. Australia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Gene Therapy Treatment Market

• 13.1. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Gene Therapy Treatment Market

• 14.1. South Korea Personalized Gene Therapy Treatment Market Overview
• 14.2. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Gene Therapy Treatment Market

• 15.1. Western Europe Personalized Gene Therapy Treatment Market Overview
• 15.2. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Gene Therapy Treatment Market

• 16.1. UK Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Gene Therapy Treatment Market

• 17.1. Germany Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Gene Therapy Treatment Market

• 18.1. France Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Gene Therapy Treatment Market

• 19.1. Italy Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Gene Therapy Treatment Market

• 20.1. Spain Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Gene Therapy Treatment Market

• 21.1. Eastern Europe Personalized Gene Therapy Treatment Market Overview
• 21.2. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Gene Therapy Treatment Market

• 22.1. Russia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Gene Therapy Treatment Market

• 23.1. North America Personalized Gene Therapy Treatment Market Overview
• 23.2. North America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Gene Therapy Treatment Market

• 24.1. USA Personalized Gene Therapy Treatment Market Overview
• 24.2. USA Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Gene Therapy Treatment Market

• 25.1. Canada Personalized Gene Therapy Treatment Market Overview
• 25.2. Canada Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Gene Therapy Treatment Market

• 26.1. South America Personalized Gene Therapy Treatment Market Overview
• 26.2. South America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Gene Therapy Treatment Market

• 27.1. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Gene Therapy Treatment Market

• 28.1. Middle East Personalized Gene Therapy Treatment Market Overview
• 28.2. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Gene Therapy Treatment Market

• 29.1. Africa Personalized Gene Therapy Treatment Market Overview
• 29.2. Africa Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Gene Therapy Treatment Market Competitive Landscape And Company Profiles

• 30.1. Personalized Gene Therapy Treatment Market Competitive Landscape
• 30.2. Personalized Gene Therapy Treatment Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Gene Therapy Treatment Market Other Major And Innovative Companies

• 31.1. BioMarin Pharmaceutical Inc.
• 31.2. Sarepta Therapeutics Inc.
• 31.3. Rocket Pharmaceuticals Inc.
• 31.4. REGENXBIO Inc.
• 31.5. Intellia Therapeutics Inc.
• 31.6. Beam Therapeutics Inc.
• 31.7. Adaptimmune Therapeutics plc
• 31.8. Krystal Biotech Inc.
• 31.9. Miltenyi Biomedicine GmbH
• 31.10. Bluebird Bio Inc.
• 31.11. uniQure N.V.
• 31.12. Mesoblast Limited
• 31.13. Astellas Gene Therapies Inc.
• 31.14. Adverum Biotechnologies Inc.

32. Global Personalized Gene Therapy Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Gene Therapy Treatment Market

34. Recent Developments In The Personalized Gene Therapy Treatment Market

35. Personalized Gene Therapy Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Gene Therapy Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Gene Therapy Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Gene Therapy Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer